Ancora Bio
CA - Palo AltoBiotechnology
Focus: Ancora Bio is a private biotechnology company focused on developing multi-specific antibodies for oncology and other therapeutic areas. Founded in 2021 and headquartered in Palo Alto, CA, the company is at an early stage of clinical development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
0
About Ancora Bio
AI assessmentNot HiringNo open roles listed right now. Follow Ancora Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ANC-501
Major Depressive DisorderClinical Trials (1)
NCT05439603ANC-501 in the Treatment of Adults With Major Depressive Disorder
Phase 2Help build intelligence for Ancora Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.